Clinical Trial Update: Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating delayed initiation of olaparib maintenance in platinum-sensitive recurrent ovarian cancer was terminated, with results posted in 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: Sarah E Taylor | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-08-20